Neurofeedback Market Report 2026

The neurofeedback market size has grown rapidly in recent years. It will grow from $1.57 billion in 2025 to $1.74 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing awareness of mental health therapies, rising prevalence of neurological disorders, growth in alternative and non-invasive treatments, expansion of neurotherapy clinics, availability of eeg monitoring technologies.

The neurofeedback market size is expected to see rapid growth in the next few years. It will grow to $2.6 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for personalized mental health treatments, rising adoption of digital therapeutics, expansion of remote neurofeedback training, growing integration of ai in brain signal analysis, increasing focus on cognitive wellness optimization. Major trends in the forecast period include increasing adoption of eeg-based training systems, rising use of personalized neurofeedback protocols, growing integration of software-based brain training tools, expansion of home-based neurofeedback solutions, enhanced focus on cognitive performance improvement.

The rising prevalence of neurodegenerative diseases is expected to drive the growth of the neurofeedback market in the coming years. Neurodegenerative diseases are disorders that gradually impair the brain and nervous system, resulting in difficulties with memory, movement, and cognitive functions. The increase in these conditions is primarily attributed to an aging population, improved diagnosis and awareness, and lifestyle factors. Neurofeedback can serve as a valuable approach in managing Parkinson's disease by supporting improvements in motor control, cognitive abilities, emotional regulation, and overall brain health. It can also be used to enhance sleep quality, which is often disrupted in Parkinson's patients; by promoting brainwave patterns that encourage restful sleep, patients may experience better overall health and symptom management. For example, in March 2023, the Alzheimer's Association, a US-based nonprofit voluntary health organization, reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, and this number is projected to reach 13.8 million by 2060. Consequently, the growing prevalence of neurodegenerative diseases is contributing to the expansion of the neurofeedback market.

Major companies operating in the neurofeedback market are concentrating on creating innovative solutions, such as personalized at-home brain training systems, to address the growing demand for cognitive enhancement, stress management, and overall mental wellbeing. Personalized at-home brain training systems combine advanced neurofeedback technology with supplementary features like heart coherence training, transcranial photobiomodulation (light stimulation), brain performance assessment, and guided meditation. For example, in October 2023, Sens.ai Inc., a Canada-based neurofeedback and personalized brain-training company, introduced its Sens.ai system, a novel 5-in-1 brain training technology. The system features a headset and a gamified app, designed to assess brain processing speed using event-related potentials (ERPs), deliver multisensory meditation exercises, provide targeted light stimulation boosts, monitor cognitive performance, and adapt its programs over time based on user progress. This closed-loop design enables users to enhance focus, manage stress, improve sleep, and achieve higher cognitive and psychological performance from home.

In August 2024, Divergence Neuro Technologies Inc., a Canada-based neurotechnology company, collaborated with Synchroni Scientific Instruments Inc. to expand access to high-quality, cost-effective EEG and biometric measurement devices for remote and at-home neurofeedback and biofeedback use. Through this collaboration, Divergence will integrate Synchroni’s dry, Bluetooth-enabled wireless devices, the Uno and Trio, into its platform, allowing clinicians and coaches to employ single-sensor and dual-sensor EEG setups alongside EKG monitoring for flexible treatment options. Synchroni Scientific Instruments Inc. is a Canada-based biomedical device manufacturer specializing in mobile EEG and EKG sensing solutions.

Major companies operating in the neurofeedback market are Thought Technology Ltd., NeurOptimal, Brain Master Technologies Inc., Mind Media Inc., Neurofield Inc., Bee Medic LLC, Mitsar Co. Ltd., Mind Alive Inc., ANT Neuro b.v., EEG Info, NeuroSky, EMOTIV Inc., Neuroelectrics, Brain Vision LLC, Myndlift, BrainCore, NIRx Medical Technologies LLC, Mindfield Biosystems Ltd., NeuroCare Group, Brainquiry.

North America was the largest region in the neurofeedback market in 2025. The regions covered in the neurofeedback market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurofeedback market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the neurofeedback market by increasing costs of imported EEG sensors, amplifiers, software systems, and electronic components used in neurofeedback devices. Clinics and therapy centers in North America and Europe are most affected due to reliance on imported neurotechnology equipment, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are raising system prices and slowing adoption in smaller practices. However, they are also encouraging local development of neurofeedback software, domestic assembly of devices, and innovation in affordable brain training solutions.

The neurofeedback market research report is one of a series of new reports that provides neurofeedback market statistics, including neurofeedback industry global market size, regional shares, competitors with a neurofeedback market share, detailed neurofeedback market segments, market trends and opportunities, and any further data you may need to thrive in the neurofeedback industry. This neurofeedback market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neurofeedback is a form of biofeedback that focuses on training individuals to regulate their brain activity. It involves real-time monitoring of brainwaves, typically through electroencephalography (EEG), to provide feedback about brain function. The objective is to help the brain enhance its activity regulation, resulting in improved cognitive, emotional, and physiological performance.

The primary product types in neurofeedback include amplifiers, electrodes or sensors, and computer software. Neurofeedback amplifiers are specialized electronic devices that strengthen and clarify the brain signals detected by electrodes. The different systems comprise frequency or power neurofeedback systems, slow cortical potential neurofeedback (SCP-NF) systems, low-energy neurofeedback systems (LENS), hemoencephalographic (HEG) neurofeedback systems, live z-score neurofeedback systems, low-resolution electromagnetic tomography (LORETA), and functional magnetic resonance imaging (fMRI). These systems are applied in conditions such as attention deficit hyperactivity disorder (ADHD), anxiety, depression, epilepsy, insomnia, drug addiction, schizophrenia, and more, and are utilized by various end-users including hospitals, physician offices, and ambulatory surgical centers (ASCs).

The neurofeedback market consists of revenues earned by entities by providing home-based neurofeedback, electroencephalogram neurofeedback, alpha-theta neurofeedback, z-score neurofeedback and power neurofeedback. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurofeedback market also includes sales of portable EEG headsets, headbands, caps, and wireless EEG devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.